Company intelligence / Profile preview

Launch One Acquisition

Oakland, California, United States

Ownership: Private
Development stage: Other

Overview

Launch One Acquisition is a special purpose acquisition company (SPAC) with no significant operations, formed to merge with or acquire companies in the life sciences sector. As of August 2025, it is in the process of merging with Minovia Therapeutics, a clinical-stage mitochondrial cell therapy biotech, to form Mito US One—a new Nasdaq-listed mitochondrial medicine company. At present, Launch One has no clinical programs or products of its own.[1][2][6][8][9]

Industry: Investors

Partnerships

Minovia Therapeutics

Beyond the preview

Go deeper on Launch One Acquisition.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Launch One Acquisition.

Explore the full profile